New heart device aims to zap away irregular heartbeat

NCT ID NCT05164107

Recruiting now Disease control Sponsor: Kardium Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device that uses short bursts of energy (pulsed field ablation) to treat atrial fibrillation, a common heart rhythm problem. The device maps the heart and then delivers energy to specific areas to correct the rhythm. Researchers will enroll 175 people to see if the procedure is safe and works well.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Globe Mapping and Pulsed Field Ablation System (Globe PF System)
What this could lead to: If successful, this could provide a safer, more precise way to treat atrial fibrillation, potentially reducing complications and improving outcomes.
What could go wrong: This is an early pilot study with no control group, so results are preliminary. The procedure carries risks like any heart ablation, including bleeding, heart damage, or irregular heartbeats.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION

Contacts and locations

Locations

Motol and Homolka University Hospital
RECRUITING

Prague, 150 00, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.